X-BIOTIX THERAPEUTICS, INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2023–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	1	1
2025	—	4	1
2024	—	4	1
2023	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
INNOVATIVE FEDERAL STRATEGIES, LLC	—	14

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	11
SENATE	9

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	13
Health Issues	Health Issues	8

Bills Explicitly Cited (13)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: —

Matched citations: H.R.5304

S. 2587119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: —

Matched citations: S.2587

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: —

Matched citations: H.R.5304

S. 2587119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: —

Matched citations: S.2587

Show 9 more cited filings

H.R. 9029118th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

2024 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: H.R.9029

S. 4942118th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

2024 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: S.4942

H.R. 9029118th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

2024 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: H.R.9029

S. 4942118th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

2024 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: S.4942

H.R. 9029118th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

2024 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.9029/S.____, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: H.R.9029

H.R. 5894118th Congress

Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.

2023 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: H.R5894

S. 2624118th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024

2023 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: S.2624

H.R. 5894118th Congress

Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.

2023 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: H.R5894

S. 2624118th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024

2023 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024, Title II, all provisions related to Antimicrobial Resistance.

Client expense: — · Firm income: $10,000

Matched citations: S.2624

Source: Senate LDA

X-BIOTIX THERAPEUTICS, INC. — Lobbying Disclosure | Poliscope